Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-04-27 | Mr. Christopher Paul WillcoxExecutive Officer, Deputy President, Head of Wholesale & Chairman of Investment Management | -5,05k | 38,97k | Sale to Issuer | 7,71 | 14,59k | -25,73% |
| 2026-04-24 | Mr. Christopher Paul WillcoxExecutive Officer, Deputy President, Head of Wholesale & Chairman of Investment Management | -1,36M | 11,18M | Derivative Exercise and Sale | 8,21 | 14,59k | - |
| 2026-04-27 | Mr. Christopher Paul WillcoxExecutive Officer, Deputy President, Head of Wholesale & Chairman of Investment Management | 9,90k | 0,00 | Derivative Exercise and Retained Stock | - | 14,59k | 211,27% |
| 2026-04-27 | Mr. Yutaka NakajimaRepresentative Executive Officer, Deputy President & Director | -4,70k | 36,21k | Sale to Issuer | 7,71 | 682,74k | -0,68% |
| 2026-04-24 | Mr. Yutaka NakajimaRepresentative Executive Officer, Deputy President & Director | -193,02k | 1,58M | Derivative Exercise and Sale | 8,21 | 682,74k | - |
| 2026-04-27 | Mr. Yutaka NakajimaRepresentative Executive Officer, Deputy President & Director | 9,90k | 0,00 | Derivative Exercise and Retained Stock | - | 682,74k | 1,47% |
| 2026-04-27 | Mr. Kentaro OkudaPresident, Group CEO, Representative Executive Officer & Director | -26,71k | 205,90k | Sale to Issuer | 7,71 | 529,19k | -4,80% |
| 2026-04-24 | Mr. Kentaro OkudaPresident, Group CEO, Representative Executive Officer & Director | -325,48k | 2,67M | Derivative Exercise and Sale | 8,21 | 529,19k | - |
| 2026-04-27 | Mr. Kentaro OkudaPresident, Group CEO, Representative Executive Officer & Director | 57,80k | 0,00 | Derivative Exercise and Retained Stock | - | 529,19k | 12,26% |
| 2026-04-27 | Yukiko OzakiSenior MD, Chief HR Officer & Chief Health Officer | -1,47k | 11,31k | Sale to Issuer | 7,71 | 20,99k | -6,53% |
| 2026-04-24 | Yukiko OzakiSenior MD, Chief HR Officer & Chief Health Officer | -2,90k | 23,78k | Derivative Exercise and Sale | 8,21 | 20,99k | - |
| 2026-04-27 | Yukiko OzakiSenior MD, Chief HR Officer & Chief Health Officer | 4,90k | 0,00 | Derivative Exercise and Retained Stock | - | 20,99k | 30,46% |
| 2026-04-27 | Mr. Takumi KitamuraExecutive Officer & Chief Transformation Officer | -4,33k | 33,38k | Sale to Issuer | 7,71 | 145,53k | -2,89% |
| 2026-04-24 | Mr. Takumi KitamuraExecutive Officer & Chief Transformation Officer | -85,91k | 705,29k | Derivative Exercise and Sale | 8,21 | 145,53k | - |
| 2026-04-27 | Mr. Takumi KitamuraExecutive Officer & Chief Transformation Officer | 9,10k | 0,00 | Derivative Exercise and Retained Stock | - | 145,53k | 6,67% |
| 2026-04-27 | Mr. Go SugiyamaExecutive Officer, Deputy President & Head of Banking | -12,92k | 99,63k | Sale to Issuer | 7,71 | 53,81k | -19,36% |
| 2026-04-24 | Mr. Go SugiyamaExecutive Officer, Deputy President & Head of Banking | -42,06k | 345,31k | Derivative Exercise and Sale | 8,21 | 53,81k | - |
| 2026-04-27 | Mr. Go SugiyamaExecutive Officer, Deputy President & Head of Banking | 27,80k | 0,00 | Derivative Exercise and Retained Stock | - | 53,81k | 106,87% |
| 2026-04-27 | Naotaka MinamiSenior MD & Chief Strategy Officer | -1,99k | 15,32k | Sale to Issuer | 7,71 | 29,08k | -6,40% |
| 2026-04-24 | Naotaka MinamiSenior MD & Chief Strategy Officer | -503,00 | 4,13k | Derivative Exercise and Sale | 8,21 | 29,08k | - |
| 2026-04-27 | Naotaka MinamiSenior MD & Chief Strategy Officer | 4,00k | 0,00 | Derivative Exercise and Retained Stock | - | 29,08k | 15,95% |
| 2026-04-24 | Mr. Koji NagaiChairman of the Board | -220,64k | 35,27M | Derivative Exercise and Sale | 159,84 | 512,94k | - |
| 2026-04-27 | Mr. Toshiyasu IiyamaChief of Staff, Executive Officer, Head of Well Growing Institute & Deputy President | -49,45k | 381,26k | Sale to Issuer | 7,71 | 301,66k | -14,08% |
| 2026-04-24 | Mr. Toshiyasu IiyamaChief of Staff, Executive Officer, Head of Well Growing Institute & Deputy President | -60,75k | 498,72k | Derivative Exercise and Sale | 8,21 | 301,66k | - |
| 2026-04-27 | Mr. Toshiyasu IiyamaChief of Staff, Executive Officer, Head of Well Growing Institute & Deputy President | 107,30k | 0,00 | Derivative Exercise and Retained Stock | - | 301,66k | 55,21% |
| 2026-04-27 | Mr. Sotaro KatoExecutive Officer & Chief Risk Officer | 42,30k | 0,00 | Derivative Exercise and Retained Stock | - | 62,77k | 206,60% |
| 2026-04-24 | Mr. Sotaro KatoExecutive Officer & Chief Risk Officer | -35,74k | 293,39k | Derivative Exercise and Sale | 8,21 | 62,77k | - |
| 2026-04-27 | Mr. Sotaro KatoExecutive Officer & Chief Risk Officer | -22,48k | 173,34k | Sale to Issuer | 7,71 | 62,77k | -26,37% |
| 2026-04-27 | Akihito TobariExec. VP & Director | 10,50k | 0,00 | Derivative Exercise and Retained Stock | - | 105,14k | 11,09% |
| 2026-04-27 | Akihito TobariExec. VP & Director | -6,60k | 50,90k | Derivative Exercise and Sale | 7,71 | 105,14k | - |
| 2026-04-27 | Hiroyasu KoikeInsider | 5,26k | 0,00 | Derivative Exercise and Retained Stock | - | 113,65k | 4,85% |
| 2026-04-27 | Hiroyasu KoikeInsider | -4,74k | 36,58k | Derivative Exercise and Sale | 7,71 | 113,65k | - |
| 2026-04-27 | Takako MoriSenior MD of General Counsel & Joint CCO | 4,12k | 0,00 | Derivative Exercise and Retained Stock | - | 22,93k | 21,92% |
| 2026-04-27 | Takako MoriSenior MD of General Counsel & Joint CCO | -3,78k | 29,14k | Derivative Exercise and Sale | 7,71 | 22,93k | - |
| 2026-04-27 | Akio HoriSenior Managing Director of Group IT & Transformation | 3,15k | 0,00 | Derivative Exercise and Retained Stock | - | 59,34k | 5,60% |
| 2026-04-27 | Akio HoriSenior Managing Director of Group IT & Transformation | -2,95k | 22,76k | Derivative Exercise and Sale | 7,71 | 59,34k | - |
| 2026-04-27 | Hiroyuki MoriuchiExecutive Officer & CFO | 4,82k | 0,00 | Derivative Exercise and Retained Stock | - | 30,68k | 18,66% |
| 2026-04-27 | Hiroyuki MoriuchiExecutive Officer & CFO | -4,38k | 33,74k | Derivative Exercise and Sale | 7,71 | 30,68k | - |
| 2026-04-27 | Yuko HoriuchiSenior Managing Director of Group Finance | 2,77k | 0,00 | Derivative Exercise and Retained Stock | - | 18,45k | 17,67% |
| 2026-04-27 | Yuko HoriuchiSenior Managing Director of Group Finance | -2,63k | 20,28k | Derivative Exercise and Sale | 7,71 | 18,45k | - |
| 2026-04-27 | Mr. Masahiro GotoHead of Executive Management Headquarters & Senior MD | 39,11k | 0,00 | Derivative Exercise and Retained Stock | - | 243,37k | 19,14% |
| 2026-04-27 | Mr. Masahiro GotoHead of Executive Management Headquarters & Senior MD | -30,69k | 236,65k | Derivative Exercise and Sale | 7,71 | 243,37k | - |
| 2026-03-25 | Mr. Masahiro IshizukaIndependent Outside Director | 238,19 | 1,92k | Kauf | 8,05 | 10,24k | 2,38% |
| 2026-03-25 | Mr. Shoji OgawaNon-Executive Director | 238,19 | 1,92k | Kauf | 8,05 | 58,42k | 0,41% |
| 2026-03-25 | Yukiko OzakiSenior MD, Chief HR Officer & Chief Health Officer | 7,94 | 63,91 | Kauf | 8,05 | 17,55k | 0,05% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
